Existing data on tranexamic acid (TXA) in rhinoplasty are mixed.
Objective:
Compare blood loss, edema, and bruising in patients undergoing septorhinoplasty with or without intravenous (IV) TXA, measured by estimated blood loss and photograph review of edema/ecchymosis.
Design:
Randomized controlled trial (NCT05774717).
Methods:
Patients undergoing open septorhinoplasty were eligible. Participants were randomized to receive 1 g IV TXA preoperatively or routine medications only. Intraoperative bleeding was measured using the Boezaart scale and sponge saturation. Patients rated periorbital edema/ecchymosis at 1 week. Photos were reviewed by a facial plastic surgeon to grade edema/ecchymosis.
Results:
There were 139 participants: 73 (53%) female, mean age of 42 ± 15 years, and 13% revision procedures. Sixty-nine (50%) received TXA. Boezaart scores were 2.25 and 2.41 (p = 0.3), and sponge scores were 0.76 and 0.84 (p = 0.4) in the TXA and control groups, respectively. Postoperative edema/ecchymosis were 1.15/1.19 out of 4 in the TXA group, and 0.97/1.05 in the control group. Surgeon-graded edema/ecchymosis were 1.78/1.76 (TXA) and 1.82/1.86 (control). There was no difference in epistaxis, pain, or appearance satisfaction.
Conclusions:
In this study, there was no difference in bleeding, edema, ecchymosis, or postoperative experience associated with TXA.
Get full access to this article
View all access options for this article.
References
1.
TengbornL, BlombäckM, BerntorpE. Tranexamic acid–an old drug still going strong and making a revival. Thromb Res. 2015; 135(2):231–242; doi: 10.1016/j.thromres.2014.11.012
2.
RobertsI, ShakurH, CoatsT, et al.The CRASH-2 trial: A randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013; 17(10):1–79; doi: 10.3310/hta17100
3.
FouchePF, SteinC, NicholsM, et al.Tranexamic acid for traumatic injury in the emergency setting: A systematic review and bias-adjusted meta-analysis of randomized controlled trials. Ann Emerg Med. 2024; 83(5):435–445; doi: 10.1016/j.annemergmed.2023.10.004
4.
CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): A randomised, placebo-controlled trial. Lancet. 2019; 394(10210):1713–1723; doi: 10.1016/S0140-6736(19)32641-8 doi: 10.1016/S0140-6736(19)32233-0 Erratum in: Lancet. 2019 Nov 9;394(10210):1712
5.
DevereauxPJ, MarcucciM, PainterTW, et al;POISE-3 Investigators. Tranexamic acid in patients undergoing noncardiac surgery. N Engl J Med. 2022; 386(21):1986–1997; doi: 10.1056/NEJMoa2201171
6.
LeePL, YangKS, TsaiHW, et al.Tranexamic acid for gastrointestinal bleeding: A systematic review with meta-analysis of randomized clinical trials. Am J Emerg Med. 2021; 45:269–279; doi: 10.1016/j.ajem.2020.08.062
7.
CheemaHA, AhmadAB, EhsanM, et al.Tranexamic acid for the prevention of blood loss after cesarean section: An updated systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2023; 5(8):101049; doi: 10.1016/j.ajogmf.2023.101049Erratum in: Am J Obstet Gynecol MFM. 2023 Dec;5(12):101196. doi: 10.1016/j.ajogmf.2023.101196
8.
ZhangS, XiaoC, YuW, et al.Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: A randomized controlled trial. Eur J Trauma Emerg Surg. 2022; 48(2):731–741; doi: 10.1007/s00068-020-01387-0
9.
YassiN, ZhaoH, ChurilovL, et al;STOP-MSU Trial Investigators. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): An international, double-blind, randomised, phase 2 trial. Lancet Neurol. 2024; 23(6):577–587; doi: 10.1016/S1474-4422(24)00128-5
10.
LasockiS, CapdevilaX, VielleB, et al;SFAR research network. Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): A multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial. Lancet Haematol. 2023; 10(9):e747–e755; doi: 10.1016/S2352-3026(23)00163-1
11.
SentilhesL, WinerN, AzriaE, et al;Groupe de Recherche en Obstétrique et Gynécologie. Tranexamic acid for the prevention of blood loss after vaginal delivery. N Engl J Med. 2018; 379(8):731–742; doi: 10.1056/NEJMoa1800942
12.
TsanSEH, ViknaswaranNL, CheongCC, et al.Prophylactic intravenous tranexamic acid and thromboembolism in non-cardiac surgery: A systematic review, meta-analysis and trial sequential analysis. Anaesthesia. 2023; 78(9):1153–1161; doi: 10.1111/anae.16058
13.
JanapalaRN, TranQK, PatelJ, et al.Efficacy of topical tranexamic acid in epistaxis: A systematic review and meta-analysis. Am J Emerg Med. 2022; 51:169–175; doi: 10.1016/j.ajem.2021.10.043Epub 2021 Nov 1
14.
JonesKD, HatlevigC, ThompsonJA, et al.Impact of a tranexamic acid dosing practice guideline in reducing blood product administration in pediatric scoliosis surgery. Aana J. 2024; 92(5):363–371.
15.
RashidMM, DasS, SarkerAC, et al.Effect of tranexamic acid on progression of hematoma in traumatic brain injury: A randomized controlled trial. Mymensingh Med J. 2024 Oct;33(4):1088–1096.
16.
ZhaoM, LuoY, GuoZ, et al.The efficacy of tranexamic acid in craniomaxillofacial surgery: A systematic review of randomized controlled trials. J Craniofac Surg. 2023; 34(8):2437–2441; doi: 10.1097/SCS.0000000000009724
17.
FuR, LiuC, YanY, et al.Tranexamic acid in craniomaxillofacial surgery: A meta-analysis and systematic review. Facial Plast Surg Aesthet Med. 2021; 23(6):422–429; doi: 10.1089/fpsam.2020.0590
18.
EhresmanJ, PenningtonZ, SchillingA, et al.Cost-benefit analysis of tranexamic acid and blood transfusion in elective lumbar spine surgery for degenerative pathologies. J Neurosurg Spine. 2020; 33(2):177–185; doi: 10.3171/2020.1.SPINE191464
19.
ShiJ, ZhouC, LiuS, et al.Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial. Am Heart J. 2020; 222:147–156; doi: 10.1016/j.ahj.2019.09.010
20.
CasaresJA, JaramilloAP, NizamudeenS, et al.Evaluating the effectiveness of tranexamic acid vs. Placebo in cardiac surgery: A systematic review and meta-analysis. Cureus. 2024; 16(6):e63089; doi: 10.7759/cureus.63089
21.
WangE, WangY, LiY, et al.Tranexamic acid is associated with improved hemostasis in elderly patients undergoing coronary-artery surgeries in a retrospective cohort study. Front Surg. 2023; 10:1117974; doi: 10.3389/fsurg.2023.1117974
22.
WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial. Lancet. 2017; 389(10084):2105–2116; doi: 10.1016/S0140-6736(17)30638-4Epub 2017 Apr 26. Erratum in: Lancet. 2017 May 27;389(10084):2104. doi: 10.1016/S0140-6736(17)31220-5
23.
LourijsenE, AvdeevaK, GanKL, et al.Tranexamic acid for the reduction of bleeding during functional endoscopic sinus surgery. Cochrane Database Syst Rev. 2023; 2(2):CD012843; doi: 10.1002/14651858.CD012843.pub2
24.
LuetzenbergFS, Lyford-PikeS. Modern use of tranexamic acid in facial plastic surgery. Curr Opin Otolaryngol Head Neck Surg. 2023; 31(4):219–223; doi: 10.1097/MOO.0000000000000886
25.
RohrichRJ, ChoMJ. The role of tranexamic acid in plastic surgery: Review and technical considerations. Plast Reconstr Surg. 2018; 141(2):507–515; doi: 10.1097/PRS.0000000000003926
26.
HoffmannDF, CookTA, QuatelaVC, et al.Steroids and rhinoplasty. A double-blind study. Arch Otolaryngol Head Neck Surg. 1991; 117(9):990–993; discussion 994; doi: 10.1001/archotol.1991.01870210062009
27.
BoezaartAP, van der MerweJ, CoetzeeA. Comparison of sodium nitroprusside- and esmolol-induced controlled hypotension for functional endoscopic sinus surgery. Can J Anaesth. 1995; 42(5 Pt 1):373–376.
28.
HabibiAF, JalaliMM, AshrafA, et al.Evaluation of applying topical tranexamic acid to control septorhinoplasy - induced hemorrhage. Am J Otolaryngol. 2022; 43(5):103514; doi: 10.1016/j.amjoto.2022.103514
29.
GutierrezRWH, GobboHR, HeringerLDFL. Tranexamic acid in patients undergoing rhinoplasty: An updated systematic review and meta-analysis of randomized controlled trials. Aesthetic Plast Surg. 2024; 48(11):2076–2085; doi: 10.1007/s00266-023-03768-3
30.
AvciH. The effect of different dose regimens of tranexamic acid in reducing blood loss in rhinoplasty: A prospective randomized controlled study. J Craniofac Surg. 2021; 32(5):e442–e444; doi: 10.1097/SCS.0000000000007247
31.
MehdizadehM, GhassemiA, KhakzadM, et al.Comparison of the effect of dexamethasone and tranexamic acid, separately or in combination on post-rhinoplasty edema and ecchymosis. Aesthetic Plast Surg. 2018; 42(1):246–252; doi: 10.1007/s00266-017-0969-x
32.
SakallioğluÖ, PolatC, SoyluE, et al.The efficacy of tranexamic acid and corticosteroid on edema and ecchymosis in septorhinoplasty. Ann Plast Surg. 2015; 74(4):392–396; doi: 10.1097/SAP.0b013e3182a1e527
33.
VaghardoostR, Ahmadi DahajA, Haji MohammadM, et al.Evaluating the effect of tranexamic acid local injection on the intraoperative bleeding amount and the postoperative edema and ecchymosis in primary rhinoplasty patients: A randomized clinical trial. Aesthetic Plast Surg. 2024; 48(4):702–708; doi: 10.1007/s00266-023-03441-9
34.
VuralO, InanS, BuyukluAF. The effect of topical tranexamic acid on postrhinoplasty periorbital ecchymosis and eyelid edema. Plast Reconstr Surg. 2024; 153(3):609–617; doi: 10.1097/PRS.0000000000010631
35.
AfzaliSL, PanahiH, GanjiF, et al.Re-Evaluating the effect of preoperative tranexamic acid on blood loss and field quality during rhinoplasty: A randomized double-blinded controlled trial. Aesthetic Plast Surg. 2022; 46(3):1314–1320; doi: 10.1007/s00266-021-02594-9
36.
BeikaeiM, GhazipourA, DerakhshandeV, et al.Evaluating the effect of intravenous tranexamic acid on intraoperative bleeding during elective rhinoplasty surgery. Biomed Pharmacol J. 2015; 8(October Spl Edition):753–759.
37.
EftekharianHR, RajabzadehZ. The efficacy of preoperative oral tranexamic acid on intraoperative bleeding during rhinoplasty. J Craniofac Surg. 2016; 27(1):97–100; doi: 10.1097/SCS.0000000000002273
38.
GhavimiMA, Taheri TaleshK, GhoreishizadehA, et al.Efficacy of tranexamic acid on side effects of rhinoplasty: A randomized double-blind study. J Craniomaxillofac Surg. 2017; 45(6):897–902; doi: 10.1016/j.jcms.2017.03.001
39.
Haddady-AbianehS, RahmatiJ, DelavariC, et al.Comparison of the effect of injectable tranexamic acid and inhaled desmopressin in controlling bleeding and ecchymosis in open rhinoplasty. World J Plast Surg. 2022; 11(3):24–27; doi: 10.52547/wjps.11.3.24
40.
Sezen GöktaşS, YenigünA, SütcüAO, et al.Tranexamic acid and rhinoplasty: How do different administration routes affect effectiveness? Aesthetic Plast Surg. 2024; 48(17):3284–3291; doi: 10.1007/s00266-024-03951-0
41.
de VasconcellosSJA, do Nascimento-JúniorEM, de Aguiar MenezesMV, et al.Preoperative tranexamic acid for treatment of bleeding, edema, and ecchymosis in patients undergoing rhinoplasty: A systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018; 144(9):816–823; doi: 10.1001/jamaoto.2018.1381
42.
ZamanSU, ZakirI, FarazQ, et al.Effect of single-dose intravenous tranexamic acid on postoperative nasal bleed in septoplasty. Eur Ann Otorhinolaryngol Head Neck Dis. 2019; 136(6):435–438; doi: 10.1016/j.anorl.2018.10.019
43.
Ziegler RodríguezOR, De la Cruz KuG, Chávez DíazM, et al.Safety and outcomes in multiplane facial rejuvenation with tranexamic acid: A cohort study. Plast Reconstr Surg Glob Open. 2024; 12(3):e5653; doi: 10.1097/GOX.0000000000005653
44.
LaikhterE, ComerCD, ShiahE, et al.A systematic review and meta-analysis evaluating the impact of tranexamic acid administration in aesthetic plastic surgery. Aesthet Surg J. 2022; 42(5):548–558; doi: 10.1093/asj/sjab333
45.
LocketzGD, LozadaKN, BloomJD. Tranexamic acid in aesthetic facial plastic surgery: A systematic review of evidence, applications, and outcomes. Aesthet Surg J Open Forum. 2020; 2(3):ojaa029; doi: 10.1093/asjof/ojaa029
46.
BrownS, BrownT, RohrichRJ. Clinical Applications of Tranexamic Acid (TXA) in plastic and reconstructive surgery. Plast Reconstr Surg. 2024; 154(6):1253e–1263e; doi: 10.1097/PRS.0000000000011288
47.
KumarEA, MorrisLM, Michalski-McNeelyBM. Tranexamic acid in mohs micrographic surgery: A systematic review. Dermatol Surg. 2025; 51(1):17–19; doi: 10.1097/DSS.0000000000004373
48.
KochubaAL, CoombsDM, KwiecienGJ, et al.Prospective study assessing the effect of local infiltration of tranexamic acid on facelift bleeding. Aesthet Surg J. 2021; 41(4):391–397; doi: 10.1093/asj/sjaa198
49.
WeisslerJM, BanuelosJ, MolinarVE, et al.Local Infiltration of Tranexamic Acid (TXA) in Liposuction: A single-surgeon outcomes analysis and considerations for minimizing postoperative donor site ecchymosis. Aesthet Surg J. 2021; 41(7):NP820–NP828; doi: 10.1093/asj/sjaa437
50.
AusenK, FossmarkR, SpigsetO, et al.Safety and efficacy of local tranexamic acid for the prevention of surgical bleeding in soft-tissue surgery: A review of the literature and recommendations for plastic surgery. Plast Reconstr Surg. 2022; 149(3):774–787; doi: 10.1097/PRS.0000000000008884
51.
AbrahamMT, TianL, DelMauroMA, et al.Complications associated with tranexamic acid use with cutaneous flap surgery. Facial Plast Surg Aesthet Med. 2024; 26(2):203–204; doi: 10.1089/fpsam.2023.0245
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
